502 related articles for article (PubMed ID: 28636956)
21. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW
J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426
[TBL] [Abstract][Full Text] [Related]
22. Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.
Klasse PJ; LaBranche CC; Ketas TJ; Ozorowski G; Cupo A; Pugach P; Ringe RP; Golabek M; van Gils MJ; Guttman M; Lee KK; Wilson IA; Butera ST; Ward AB; Montefiori DC; Sanders RW; Moore JP
PLoS Pathog; 2016 Sep; 12(9):e1005864. PubMed ID: 27627672
[TBL] [Abstract][Full Text] [Related]
23. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers.
de Taeye SW; de la Peña AT; Vecchione A; Scutigliani E; Sliepen K; Burger JA; van der Woude P; Schorcht A; Schermer EE; van Gils MJ; LaBranche CC; Montefiori DC; Wilson IA; Moore JP; Ward AB; Sanders RW
J Biol Chem; 2018 Feb; 293(5):1688-1701. PubMed ID: 29222332
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
Bricault CA; Kovacs JM; Badamchi-Zadeh A; McKee K; Shields JL; Gunn BM; Neubauer GH; Ghantous F; Jennings J; Gillis L; Perry J; Nkolola JP; Alter G; Chen B; Stephenson KE; Doria-Rose N; Mascola JR; Seaman MS; Barouch DH
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643249
[TBL] [Abstract][Full Text] [Related]
25. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
26. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.
Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR
Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475
[TBL] [Abstract][Full Text] [Related]
27. Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes.
Tokatlian T; Kulp DW; Mutafyan AA; Jones CA; Menis S; Georgeson E; Kubitz M; Zhang MH; Melo MB; Silva M; Yun DS; Schief WR; Irvine DJ
Sci Rep; 2018 Nov; 8(1):16527. PubMed ID: 30410003
[TBL] [Abstract][Full Text] [Related]
28. Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.
Pauthner MG; Nkolola JP; Havenar-Daughton C; Murrell B; Reiss SM; Bastidas R; Prévost J; Nedellec R; von Bredow B; Abbink P; Cottrell CA; Kulp DW; Tokatlian T; Nogal B; Bianchi M; Li H; Lee JH; Butera ST; Evans DT; Hangartner L; Finzi A; Wilson IA; Wyatt RT; Irvine DJ; Schief WR; Ward AB; Sanders RW; Crotty S; Shaw GM; Barouch DH; Burton DR
Immunity; 2019 Jan; 50(1):241-252.e6. PubMed ID: 30552025
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.
de Taeye SW; Moore JP; Sanders RW
Trends Immunol; 2016 Mar; 37(3):221-232. PubMed ID: 26869204
[TBL] [Abstract][Full Text] [Related]
30. Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
Aljedani SS; Liban TJ; Tran K; Phad G; Singh S; Dubrovskaya V; Pushparaj P; Martinez-Murillo P; Rodarte J; Mileant A; Mangala Prasad V; Kinzelman R; O'Dell S; Mascola JR; Lee KK; Karlsson Hedestam GB; Wyatt RT; Pancera M
PLoS Pathog; 2021 Sep; 17(9):e1009543. PubMed ID: 34559844
[TBL] [Abstract][Full Text] [Related]
31. HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
Capucci S; Wee EG; Schiffner T; LaBranche CC; Borthwick N; Cupo A; Dodd J; Dean H; Sattentau Q; Montefiori D; Klasse PJ; Sanders RW; Moore JP; Hanke T
PLoS One; 2017; 12(8):e0181886. PubMed ID: 28792942
[TBL] [Abstract][Full Text] [Related]
32. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
Sliepen K; Ozorowski G; Burger JA; van Montfort T; Stunnenberg M; LaBranche C; Montefiori DC; Moore JP; Ward AB; Sanders RW
Retrovirology; 2015 Sep; 12():82. PubMed ID: 26410741
[TBL] [Abstract][Full Text] [Related]
33. Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies.
Feng Y; Tran K; Bale S; Kumar S; Guenaga J; Wilson R; de Val N; Arendt H; DeStefano J; Ward AB; Wyatt RT
PLoS Pathog; 2016 Aug; 12(8):e1005767. PubMed ID: 27487086
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) model.
Moyo-Gwete T; Ayres F; Mzindle NB; Makhado Z; Manamela NP; Richardson SI; Kitchin D; van Graan S; van Heerden J; Parbhoo N; Chege GK; Moore PL
Sci Rep; 2024 Jun; 14(1):13311. PubMed ID: 38858452
[TBL] [Abstract][Full Text] [Related]
35. Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.
Nkolola JP; Peng H; Settembre EC; Freeman M; Grandpre LE; Devoy C; Lynch DM; La Porte A; Simmons NL; Bradley R; Montefiori DC; Seaman MS; Chen B; Barouch DH
J Virol; 2010 Apr; 84(7):3270-9. PubMed ID: 20053749
[TBL] [Abstract][Full Text] [Related]
36. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
[TBL] [Abstract][Full Text] [Related]
37. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
38. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.
Cirelli KM; Carnathan DG; Nogal B; Martin JT; Rodriguez OL; Upadhyay AA; Enemuo CA; Gebru EH; Choe Y; Viviano F; Nakao C; Pauthner MG; Reiss S; Cottrell CA; Smith ML; Bastidas R; Gibson W; Wolabaugh AN; Melo MB; Cossette B; Kumar V; Patel NB; Tokatlian T; Menis S; Kulp DW; Burton DR; Murrell B; Schief WR; Bosinger SE; Ward AB; Watson CT; Silvestri G; Irvine DJ; Crotty S
Cell; 2019 May; 177(5):1153-1171.e28. PubMed ID: 31080066
[TBL] [Abstract][Full Text] [Related]
39. Exploration of a Sequential Gp140-Gp145 Immunization Regimen with Heterologous Envs to Induce a Protective Cross-Reactive HIV Neutralizing Antibody Response In Non-human Primates.
Ding X; Cao K; Wang J; Wan Y; Chen Q; Ren Y; Zheng Y; Zhu M; Tian R; Wang W; Zhao C; Zhang X; Xu J
Virol Sin; 2021 Aug; 36(4):784-795. PubMed ID: 33723807
[TBL] [Abstract][Full Text] [Related]
40. Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.
Martinez-Murillo P; Tran K; Guenaga J; Lindgren G; Àdori M; Feng Y; Phad GE; Vázquez Bernat N; Bale S; Ingale J; Dubrovskaya V; O'Dell S; Pramanik L; Spångberg M; Corcoran M; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
Immunity; 2017 May; 46(5):804-817.e7. PubMed ID: 28514687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
